Percutaneous Coronary Intervention Clinical Trial
Official title:
The Effect of Virtual Reality Glasses and Ice Applıcatıon on the Level of Pain During Femoral Sheath Removal in Patients Undergoing Percutaneous Coronary Intervenion
Verified date | May 2024 |
Source | Amasya University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
It is to examine the effect of virtual reality and ice application on the pain level due to femoral sheath extraction.
Status | Completed |
Enrollment | 108 |
Est. completion date | January 4, 2023 |
Est. primary completion date | November 3, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 100 Years |
Eligibility | Inclusion Criteria: - Intervention in the femoral region, - Femoral sheath size is 6-7 fr, - Presence of only one sheath in the femoral region, - No analgesics were administered before femoral sheath removal, - Absence of serious bleeding and major hematoma in the femoral region, - Being over 18 years of age, - No communication problems, - Having a place and time orientation, - No dizziness, - Not having any psychiatric disease, - No visual, auditory or mental problems, - No previously identified cold allergy, - Being willing and willing to participate in the study, Exclusion Criteria: - Serious bleeding and major hematoma development in the femoral region, - Not applying intracoronary stent or coronary angioplasty after coronary angiography, - Vital signs are abnormal enough to prevent intervention, - Having visual, auditory and mental disabilities, - Having a communication problem, - Not being willing and able to participate in the study, - It is defined as wanting to withdraw from the study at any stage of the study or being excluded from the study by the researcher. |
Country | Name | City | State |
---|---|---|---|
Turkey | Amasya University Institute of Health Sciences | Amasya | Merkez |
Lead Sponsor | Collaborator |
---|---|
Amasya University |
Turkey,
Paice JA, Cohen FL. Validity of a verbally administered numeric rating scale to measure cancer pain intensity. Cancer Nurs. 1997 Apr;20(2):88-93. doi: 10.1097/00002820-199704000-00002. — View Citation
Wang HL, Keck JF. Foot and hand massage as an intervention for postoperative pain. Pain Manag Nurs. 2004 Jun;5(2):59-65. doi: 10.1016/j.pmn.2004.01.002. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Questionnaire | The patients' opinions regarding the application of ice and virtual reality glasses were evaluated. | "through study completion, an average of 1 year". | |
Primary | Pain Scores: Numerical rating scale | The Numeric Rating Scale is a pain screening tool, commonly used to assess pain severity at that moment in time using a min:0-max:10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable" (10). This scale is a valid and reliable scale developed to determine the pain level of patients. The numerical rating scale simplifies the description of the pain level by the patient and makes it easier for the monitoring nurse to record the patient's pain rating. That the pain increases as the score increases, and then the patient verbally tells the numerical value of the pain intensity he/she feels. Pain score was measured before femoral sheath removal (time 1), and, during femoral sheath removal (2nd time),and, immediately after femoral sheath removal (3rd time), and 30 minutes after femoral sheath removal (4th time), and1 hour after femoral sheath removal (5th time). | "through study completion, an average of 1 year". | |
Secondary | Physiological parameter | Vital parameters (Pulse rate measured in minutes) of the patients were evaluated
Pulse rate was measured before femoral sheath removal (time 1) Pulse rate was measured during femoral sheath removal (2nd time) Pulse rate was measured immediately after femoral sheath removal (3rd time) Pulse rate was measured 30 minutes after femoral sheath removal (4th time) Pulse rate was measured 1 hour after femoral sheath removal (5th time |
"through study completion, an average of 1 year". | |
Secondary | Physiological parameter | Vital parameters (respiration-rate measured in minutes) of the patients were evaluated.
Respiration rate was measured before femoral sheath removal (time 1) Respiration rate was measured during femoral sheath removal (2nd time) Respiration rate was measured immediately after femoral sheath removal (3rd time) Respiration rate was measured 30 minutes after femoral sheath removal (4th time) Respiration rate was measured 1 hour after femoral sheath removal (5th time) |
"through study completion, an average of 1 year". | |
Secondary | Physiological parameter | Vital parameters (blood pressure-measured in mmHg) of the patients were evaluated
Blood pressure was measured before femoral sheath removal (time 1) Blood pressure was measured during femoral sheath removal (2nd time) Blood pressure was measured immediately after femoral sheath removal (3rd time) Blood pressure was measured 30 minutes after femoral sheath removal (4th time) Blood pressure was measured 1 hour after femoral sheath removal (5th time) |
"through study completion, an average of 1 year". | |
Secondary | Physiological parameter | Vital parameters (body temperature measured in degrees Centigrant) of the patients were evaluated
Body temperature was measured before femoral sheath removal (time 1) Body temperature was measured during femoral sheath removal (2nd time) Body temperature was measured immediately after femoral sheath removal (3rd time) Body temperature was measured 30 minutes after femoral sheath removal (4th time) Body temperature was measured 1 hour after femoral sheath removal (5th time) |
"through study completion, an average of 1 year". |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03959072 -
Cardiac Cath Lab Staff Radiation Exposure
|
||
Not yet recruiting |
NCT05669222 -
The FAVOR V AMI Trial
|
N/A | |
Recruiting |
NCT04566497 -
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
|
N/A | |
Recruiting |
NCT05240781 -
Zotarolimus vs Sirolimus Eluting Stent in High Bleeding Risk
|
N/A | |
Recruiting |
NCT03378934 -
Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary Intervention
|
Phase 4 | |
Not yet recruiting |
NCT06025071 -
Residual Inflammatory Risk-Guided colcHicine in Elderly Trial
|
Phase 4 | |
Withdrawn |
NCT04043091 -
Coronary Angiography in Critically Ill Patients With Type II Myocardial Infarction
|
N/A | |
Completed |
NCT03085823 -
The All-comers Sirolimus-coated Balloon European Registry
|
||
Completed |
NCT02837744 -
Studying Hemostatic Effect of Axiostat® Dressing on Radial Access After Percutaneous Procedure
|
||
Completed |
NCT02044146 -
A Pharmacodynamic Study of a Personalized Strategy for P2Y12 Inhibition Versus Ticagrelor in Reducing Ischemic and Bleeding Risk
|
Phase 2/Phase 3 | |
Completed |
NCT03131271 -
Effect of Ice Bag Application to Femoral Region on Pain in Patients Undergoing Percutaneous Coronary Intervention
|
N/A | |
Completed |
NCT01156571 -
A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention (PCI) (CHAMPION PHOENIX)
|
Phase 3 | |
Completed |
NCT01135667 -
Prasugrel Versus Double Dose Clopidogrel to Treat Clopidogrel Low-responsiveness After PCI
|
Phase 4 | |
Unknown status |
NCT00751491 -
Clopidogrel Versus Adenosin in Non Urgent Percutaneous Coronary Intervention (PCI)
|
Phase 3 | |
Completed |
NCT00725868 -
Blood Endothelium Biomarkers to Predict Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention
|
N/A | |
Completed |
NCT03708588 -
Chewed Versus Integral Pill of Ticagrelor
|
Phase 4 | |
Completed |
NCT04163393 -
R-One Efficiency For PCI Evolution With Robotic Assistance
|
N/A | |
Recruiting |
NCT05554588 -
Intrathrombus Thrombolysis Versus Aspiration Thrombectomy During Primary PCI
|
N/A | |
Recruiting |
NCT06080919 -
Plaque Modification And Impact On Microcirculatory Territory After Drug-Coated Balloon Percutaneous Coronary Intervention (PLAMI).
|
N/A | |
Recruiting |
NCT05353140 -
LAAO Versus NOAC in Patients With AF and PCI
|
N/A |